Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphyloxanthin biosynthesis enzymes are a group of enzymes (CrtM, CrtN, CrtP, AldH, CrtQ, and CrtO) responsible for the production of staphyloxanthin, a golden carotenoid pigment in *Staphylococcus aureus*. This pigment acts as a virulence factor, protecting the bacteria from reactive oxygen species produced by the host immune system. Inhibiting these enzymes is a potential strategy to reduce the virulence of *S. aureus* infections.
Enzyme inhibition of staphyloxanthin biosynthetic pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphyloxanthin Biosynthesis Enzymes.